SPONSORED
By Elric Langton | 8 March 2023
I have a financial interest in Poolbeg Pharma.
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), ย a leading infectious disease-focused biopharmaceutical company,ย announces that further to its announcement on 4 October 2022, it has been granted a patent by the US Patent and Trademark Office (USPTO) for methods of treating โฆ